MERK, LLC,   Russia

Hypoglycemic agent for oral administration (derivative of sulfonylurea of ​​the second generation + biguanide)

Film-coated tablets, 2.5 mg + 500 mg and 5 mg + 500 mg.

Hypoglycemic agent for oral administration of the biguanide group

Tablets, film-coated, 500 mg, 850 mg and 1000 mg.

Hypoglycemic agent for oral administration of the biguanide group

Long-acting tablets, 1000 mg.

Hypoglycemic agent for oral administration of the biguanide group
Long-acting tablets, 500 mg.
Follicle stimulating agent

For the syringe handle:

Solution for subcutaneous administration of 22 μg / 0.5 ml, 33 μg / 0.75 ml, 66 μg / 1.5 ml.

For a new type of syringe:

A solution for subcutaneous administration was 22 μg / 0.5 ml, 33 μg / 0.75 ml, 66 μg / 1.5 ml.

Follicle stimulating agent
Lyophilizate for the preparation of a solution for subcutaneous administration, 5.5 μg (75 ME).
Thyroxine synthesis regulator - iodine drug
Tablets 100 and 200 mcg.
Beta1-blocker selective
Tablets, film-coated, 5 and 10 mg.
Beta1-blocker selective

Film-coated tablets, 2.5 mg.

Luteinizing agent
Lyophilizate for the preparation of a solution for subcutaneous injection, 250 mcg.
antithyroid agent
Tablets covered with a film membrane, 5 mg and 10 mg. For 10 or 25 tablets in a PVC / AL blister; 2, 4, 5 or 10 blisters together with the instructions for use are placed in a cardboard box.

Thyroid agent
Tablets 25, 50, 75, 88, 100, 112, 125, 137 or 150 μg.